MOTS-c
Research draft Ageing research Best evidence grade C Animal or laboratory research only
Evidence design, not proof of benefit or product approval
Holds on this record
- No supplier batch has been matched to this record. A reviewer must record batch evidence before approval.
- Not marked ready for client selection in the library.
- No human administration guide. Study routes are research descriptions, not instructions.
- Research draft. Not released customer guidance.
The nine headings
Each heading opens a plain summary, then the deeper evidence and the sources behind it.
What it is
MOTS-c is a 16-link peptide encoded within mitochondrial DNA. Mitochondria help cells use energy.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)
The history
The original intervention findings were in cells and mice. A later human exercise study measured the body's own MOTS-c.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)
How it works
Open the pathway notes below. A biological pathway is a possible chain of events in the body. The grade states where it was tested.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Each proposed mechanism
Energy sensing
Cell work linked MOTS-c to folate and purine metabolism and AMPK, an energy-sensing pathway.
Evidence note: D
Sources
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Mouse metabolism
The original study examined metabolic effects in mice. This does not prove an injected human effect.
Evidence note: C
Sources
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Go deeper
Energy sensing D
Cell work linked MOTS-c to folate and purine metabolism and AMPK, an energy-sensing pathway.
Sources
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Mouse metabolism C
The original study examined metabolic effects in mice. This does not prove an injected human effect.
Sources
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
What it helps
Open the outcome notes. They show the tested condition and what was measured. A positive marker, a mouse result and a clinical benefit are different things.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Read this before you read a benefit into it
Laboratory and animal results describe what happened in that model. They are not proven healing in a person. Human studies name their own population, outcome and limits. Both are kept apart here on purpose.
Human research found for this product
Exercise and endogenous MOTS-c in people A
| Proof grade | A |
|---|---|
| Design | Randomised exercise study; not a peptide treatment trial |
| People or model | Three exercise groups, 10 participants each |
| Number | 30 |
| Outcome measured | Circulating endogenous peptides |
| Result | Exercise-related measurements of the body's own MOTS-c were reported. This cannot show that injected MOTS-c improves energy or weight. |
| Route in the study | No MOTS-c treatment administered |
| Personal regimen | Not set. A study regimen is not a personal instruction. |
Source
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
Animal and laboratory records
MOTS-c: original cell and mouse study C
| Proof grade | C |
|---|---|
| Design | Mouse experiments with cell mechanism studies |
| People or model | Mice and cultured cells |
| Outcome measured | Metabolic response |
| Result | Mouse results included effects on insulin resistance and diet-related obesity. Human efficacy was not tested by these experiments. |
| Route in the study | Experimental mouse administration |
| Personal regimen | Not set. A study regimen is not a personal instruction. |
Source
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
Go deeper
Metabolic response C
C: Tested in Mice and cultured cells. Read the study result in the human or researcher layer. This is a tested outcome, not a promised benefit.
Sources
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
The research
Each claim keeps its own source, evidence grade and limits. This is a scoped first research edition. It is not a full review or a personal treatment plan.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)
Overall state of the evidence
Status: preclinical-only
No qualifying human MOTS-c treatment result was verified in this pass. The exercise study has grade A for its exercise design, not for MOTS-c injections.
Risk summary
No qualifying human MOTS-c treatment result was verified in this pass. The exercise study has grade A for its exercise design, not for MOTS-c injections.
What is still open
- Supplier identity and batch match have not been verified
- Full-text systematic review and complete interactions are not finished
- Exact sequence and formulation
- Human exposure and treatment evidence
- Baseline energy, exercise and glucose status
Checks a reviewer must finish first
- Exact sequence and formulation
- Human exposure and treatment evidence
- Baseline energy, exercise and glucose status
How to read the proof grades
- A: Controlled human trial. Note whether randomisation and blinding were confirmed.
- B: Small uncontrolled human study or chart review.
- C: Whole-animal intervention.
- D: Cell or other laboratory study.
- E: User reports. Kept separate and never substituted for a measured outcome.
- ungraded: Identity sources, official labels, notices, reviews and unverified claims are not assigned an efficacy grade.
Go deeper
How to read the proof Open the checked detail
A: controlled human trial. State whether it was blinded and randomized. B: small uncontrolled human study or chart review; a weak clinical comparison is marked with its design limits. C: whole-animal work. D: cells or other lab work. E: user reports.
A grade describes the kind of evidence for one claim. It does not grade every claim about a peptide or approve a product. Labels, history and regulatory reviews are named sources, not efficacy grades.
Sources
- Future Health research method (Christopher’s supplied research method; read in full · checked 2026-10-09)
Open questions Open the checked detail
Supplier identity and batch match have not been verified
Full-text systematic review and complete interactions are not finished
Exact sequence and formulation
Human exposure and treatment evidence
Baseline energy, exercise and glucose status
Research in people
Open the linked human study records. Each names the tested group, design, result and limits. Related-compound and non-treatment studies are marked so they cannot be used as product treatment proof.
Sources for this tile
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
Studies named in this tile
| Personal regimen | Not set. A study regimen is not a personal instruction. |
|---|
What people report
No user reports are recorded for this product. The library keeps human studies and user reports in separate places, so nothing is filled in here.
Each human record
Exercise and endogenous MOTS-c in people A
| Proof grade | A |
|---|---|
| Design | Randomised exercise study; not a peptide treatment trial |
| People or model | Three exercise groups, 10 participants each |
| Number | 30 |
| Outcome measured | Circulating endogenous peptides |
| Result | Exercise-related measurements of the body's own MOTS-c were reported. This cannot show that injected MOTS-c improves energy or weight. |
| Route in the study | No MOTS-c treatment administered |
| Personal regimen | Not set. A study regimen is not a personal instruction. |
Source
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
Why it is for you
This is the shared library. No client has been assessed in this record. This tile will use the person's own words, a named target and checked rule-outs after intake. A catalog entry does not mean it is suitable for someone.
Not filled in for you yet
This heading is personal. It stays blank until your own intake is reviewed and a plan is agreed with you. Nobody else's reasons or results are shown here.
What you would notice
No qualifying human MOTS-c treatment result was verified in this pass. The exercise study has grade A for its exercise design, not for MOTS-c injections.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)
Not filled in for you yet
This heading is personal. It stays blank until your own intake is reviewed and a plan is agreed with you. Nobody else's reasons or results are shown here.
How it is taken
No human route or client cycle is established by these studies. Research routes describe what was studied. They are not a client administration guide.
Sources for this tile
- MOTS-c: original cell and mouse study (Lee and colleagues · 2015 · Primary full text · checked 2026-10-08)
- Exercise and endogenous MOTS-c in people (2021 · Published abstract · checked 2026-10-08)
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)
Routes seen in the research
- No MOTS-c treatment administered
Dose and cycle fields in the library
These are blank on purpose. A personal amount, schedule, mixing or storage instruction is only written into an agreed plan after a reviewer checks the exact product.
| dose | Blank |
|---|---|
| unit | Blank |
| frequency | Blank |
| timeOfDay | Blank |
| foodTiming | Blank |
| route | Blank |
| injectionSite | Blank |
| cycleLength | Blank |
| restLength | Blank |
| titration | Blank |
| mixing | Blank |
| storage | Blank |
| expiryAfterMixing | Blank |
Identity
| What it is made of | MOTS-c is a 16-link peptide encoded within mitochondrial DNA. Mitochondria help cells use energy. |
|---|---|
| Chain length | 16 |
| Maker | Not recorded |
| Supplier batch matched | No. Not matched to a supplier batch. |
| Catalog sizes | 10mg to 40mg - Inherited reference only; stock and current product sizes unverified |
| Record checked on | 2026-10-08 |
Shared safety note
FDA flags immune reactions and impurities in several compounded peptides. Its notice also reports serious events in IV ipamorelin research, heart-rate and vessel-dilation reactions with CJC-1295, glucose concerns with GHRP-2/6, and serious case reports with melanotan II. Reports do not by themselves establish causation. This concerns proposed compounded products and routes, not every formulation worldwide.
Source
- FDA: compounding safety concerns (FDA · Official safety notice · checked 2026-10-08)